• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向NLRP3炎性小体在类风湿关节炎中的治疗潜力

Therapeutic Potential of Targeting the NLRP3 Inflammasome in Rheumatoid Arthritis.

作者信息

Gao Jie, Zhang Hongliang, Yang Yanyan, Tao Jinhui

机构信息

Department of Rheumatology and Immunology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230001, People's Republic of China.

College of Medicine and Health, Lishui University, Liandu District, No. 1 Xueyuan Road, Lishui, 323000, China.

出版信息

Inflammation. 2023 Jun;46(3):835-852. doi: 10.1007/s10753-023-01795-5. Epub 2023 Mar 10.

DOI:10.1007/s10753-023-01795-5
PMID:36897552
Abstract

NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome is a cytoplasmic multiprotein complex composed of the innate immune receptor protein NLRP3, the adapter protein apoptosis-associate speck-like protein containing a caspase recruitment domain (ASC), and the inflammatory protease cysteine-1. Pathogen-associated molecular patterns (PAMPs) or other endogenous danger-associated molecular patterns (DAMPs) activate the NLRP3 inflammasome. As part of the innate immune response, activated NLRP3 promotes GSDMD-dependent pyroptosis, and IL-1β and IL-18 are released during inflammation. Aberrantly activated NLRP3 is deeply involved in various inflammatory diseases. Due to its interaction with adaptive immunity. NLRP3 inflammation has increasingly received attention in autoimmune diseases. Rheumatoid arthritis (RA) is a classic autoimmune disease, which mainly causes bone and cartilage damage. Elevated levels of NLRP3 can be detected in the synovium of RA patients. NLRP3 overactivation is strongly associated with RA activity. Mouse models of spontaneous arthritis has shown that NLRP3/IL-1β axis is implicated in periarticular inflammation in RA. In this review, we describe the current understanding of NLRP3 activation in RA pathogenesis and dissect its impact on innate and adaptive immunity. We also discuss the potential application of specific inhibitors of NLRP3 to provide new therapeutic strategies for treating RA.

摘要

NOD样受体家族含pyrin结构域3(NLRP3)炎性小体是一种细胞质多蛋白复合物,由天然免疫受体蛋白NLRP3、衔接蛋白含半胱天冬酶募集结构域的凋亡相关斑点样蛋白(ASC)和炎性蛋白酶半胱氨酸蛋白酶-1组成。病原体相关分子模式(PAMPs)或其他内源性危险相关分子模式(DAMPs)激活NLRP3炎性小体。作为天然免疫反应的一部分,活化的NLRP3促进gasdermin D(GSDMD)依赖性细胞焦亡,炎症期间释放白细胞介素-1β(IL-1β)和白细胞介素-18(IL-18)。异常激活的NLRP3深度参与各种炎症性疾病。由于其与适应性免疫的相互作用,NLRP3炎症在自身免疫性疾病中越来越受到关注。类风湿关节炎(RA)是一种典型的自身免疫性疾病,主要导致骨和软骨损伤。在RA患者的滑膜中可检测到NLRP3水平升高。NLRP3过度激活与RA活动密切相关。自发性关节炎小鼠模型表明,NLRP3/IL-1β轴与RA的关节周围炎症有关。在这篇综述中,我们描述了目前对RA发病机制中NLRP3激活的理解,并剖析了其对天然免疫和适应性免疫的影响。我们还讨论了NLRP3特异性抑制剂的潜在应用,为治疗RA提供新的治疗策略。

相似文献

1
Therapeutic Potential of Targeting the NLRP3 Inflammasome in Rheumatoid Arthritis.靶向NLRP3炎性小体在类风湿关节炎中的治疗潜力
Inflammation. 2023 Jun;46(3):835-852. doi: 10.1007/s10753-023-01795-5. Epub 2023 Mar 10.
2
A narrative review of positive regulation of NLRP3 inflammasome in rheumatoid arthritis.类风湿关节炎中 NLRP3 炎性体的正向调控:一篇叙述性综述。
Ann Palliat Med. 2021 Dec;10(12):12877-12885. doi: 10.21037/apm-21-3472.
3
Role of the NLRP3 inflammasome in autoimmune diseases.NLRP3 炎性小体在自身免疫性疾病中的作用。
Biomed Pharmacother. 2020 Oct;130:110542. doi: 10.1016/j.biopha.2020.110542. Epub 2020 Jul 29.
4
Regulatory effect of zinc finger protein A20 on rheumatoid arthritis through NLRP3/Caspase-1 signaling axis mediating pyroptosis of HFLS- RA cells.锌指蛋白 A20 通过 NLRP3/Caspase-1 信号轴调控类风湿关节炎及介导 HFLS-RA 细胞焦亡
Cell Mol Biol (Noisy-le-grand). 2023 Aug 31;69(8):179-184. doi: 10.14715/cmb/2023.69.8.27.
5
NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis.NLRP3 炎性小体激活参与类风湿关节炎的发病机制。
Clin Exp Immunol. 2018 Nov;194(2):231-243. doi: 10.1111/cei.13167. Epub 2018 Sep 16.
6
NLRP3: A promising therapeutic target for autoimmune diseases.NLRP3:自身免疫性疾病有前途的治疗靶点。
Autoimmun Rev. 2018 Jul;17(7):694-702. doi: 10.1016/j.autrev.2018.01.020. Epub 2018 May 3.
7
NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases.NLRP3 炎性小体:连接自身免疫性疾病固有免疫和适应性免疫的检查点。
Front Immunol. 2021 Oct 11;12:732933. doi: 10.3389/fimmu.2021.732933. eCollection 2021.
8
The zebrafish NLRP3 inflammasome has functional roles in ASC-dependent interleukin-1β maturation and gasdermin E-mediated pyroptosis.斑马鱼 NLRP3 炎性小体在 ASC 依赖性白细胞介素-1β成熟和 GSDME 介导的细胞焦亡中发挥功能作用。
J Biol Chem. 2020 Jan 24;295(4):1120-1141. doi: 10.1074/jbc.RA119.011751. Epub 2019 Dec 18.
9
Caspase-1 mediated interleukin-18 activation in neutrophils promotes the activity of rheumatoid arthritis in a NLRP3 inflammasome independent manner.半胱天冬酶-1介导的中性粒细胞中白细胞介素-18激活以不依赖NLRP3炎性小体的方式促进类风湿性关节炎的活性。
Joint Bone Spine. 2016 May;83(3):282-9. doi: 10.1016/j.jbspin.2015.07.006. Epub 2016 Jan 5.
10
The NLRP3 Inflammasome as a Pathogenic Player Showing Therapeutic Potential in Rheumatoid Arthritis and Its Comorbidities: A Narrative Review.NLRP3 炎性小体作为一种致病因子,在类风湿关节炎及其合并症中具有治疗潜力:一种叙述性综述。
Int J Mol Sci. 2024 Jan 3;25(1):626. doi: 10.3390/ijms25010626.

引用本文的文献

1
Diverse functions of NLRP3 inflammasome in PANoptosis and diseases.NLRP3炎性小体在PAN细胞焦亡及疾病中的多种功能
Cell Death Discov. 2025 Aug 19;11(1):389. doi: 10.1038/s41420-025-02689-1.
2
Narirutin mitigates inflammatory arthritis and osteoporosis through modulating macrophage phenotype and osteoclastogenesis.橙皮苷通过调节巨噬细胞表型和破骨细胞生成减轻炎性关节炎和骨质疏松症。
J Orthop Translat. 2025 Aug 8;54:115-130. doi: 10.1016/j.jot.2025.07.008. eCollection 2025 Sep.
3
Ultrasound combined with microbubble enhanced renoprotective effects of NLRP3 inflammasome inhibitor MCC950 in CKD model.

本文引用的文献

1
LDC7559 Exerts Neuroprotective Effects by Inhibiting GSDMD-Dependent Pyroptosis of Microglia in Mice with Traumatic Brain Injury.LDC7559通过抑制创伤性脑损伤小鼠小胶质细胞中依赖Gasdermin D的细胞焦亡发挥神经保护作用。
J Neurotrauma. 2023 Apr;40(7-8):742-757. doi: 10.1089/neu.2021.0318. Epub 2022 Sep 9.
2
Contribution of Toll-Like Receptors and the NLRP3 Inflammasome in Rheumatoid Arthritis Pathophysiology.Toll样受体和NLRP3炎性小体在类风湿关节炎病理生理学中的作用
Immunotargets Ther. 2021 Jul 28;10:285-298. doi: 10.2147/ITT.S288547. eCollection 2021.
3
Design and Synthesis of Cathepsin-K-Activated Osteoadsorptive Fluorogenic Sentinel (OFS) Probes for Detecting Early Osteoclastic Bone Resorption in a Multiple Myeloma Mouse Model.
超声联合微泡增强NLRP3炎性小体抑制剂MCC950在慢性肾脏病模型中的肾脏保护作用
Front Pharmacol. 2025 Jul 31;16:1616542. doi: 10.3389/fphar.2025.1616542. eCollection 2025.
4
Fuzi alleviates cold-related rheumatoid arthritis via regulating gut microbiota and microbial bile acid metabolism.附子通过调节肠道微生物群和微生物胆汁酸代谢来缓解与寒冷相关的类风湿性关节炎。
Chin Med. 2025 May 15;20(1):64. doi: 10.1186/s13020-025-01123-z.
5
Sequentially assembled co-delivery nanoplatform of SIRT1 protein and SOX9-expressing plasmid for multipronged therapy of intervertebral disc degeneration.用于椎间盘退变多管齐下治疗的SIRT1蛋白与表达SOX9质粒的顺序组装共递送纳米平台
J Nanobiotechnology. 2025 May 10;23(1):340. doi: 10.1186/s12951-025-03401-2.
6
Biomaterials for Modulating the Immune Microenvironment in Rheumatoid Arthritis.用于调节类风湿关节炎免疫微环境的生物材料
BME Front. 2025 Mar 10;6:0102. doi: 10.34133/bmef.0102. eCollection 2025.
7
Natural and synthetic potential drug leads for rheumatoid arthritis probing innovative target: mitochondrial dysfunction and NLRP3 inflammasome activation.用于类风湿性关节炎研究创新靶点的天然及合成潜在药物先导物:线粒体功能障碍与NLRP3炎性小体激活
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 28. doi: 10.1007/s00210-025-03897-3.
8
Programmed Cell Death in Rheumatoid Arthritis.类风湿关节炎中的程序性细胞死亡
J Inflamm Res. 2025 Feb 18;18:2377-2393. doi: 10.2147/JIR.S499345. eCollection 2025.
9
Effectively alleviate rheumatoid arthritis via maintaining redox balance, inducing macrophage repolarization and restoring homeostasis of fibroblast-like synoviocytes by metformin-derived carbon dots.通过二甲双胍衍生的碳点维持氧化还原平衡、诱导巨噬细胞重极化并恢复成纤维样滑膜细胞的内环境稳定,有效缓解类风湿性关节炎。
J Nanobiotechnology. 2025 Jan 29;23(1):58. doi: 10.1186/s12951-025-03159-7.
10
Harnessing the Power of Machine Learning Guided Discovery of NLRP3 Inhibitors Towards the Effective Treatment of Rheumatoid Arthritis.利用机器学习的力量指导发现NLRP3抑制剂以有效治疗类风湿性关节炎。
Cells. 2024 Dec 30;14(1):27. doi: 10.3390/cells14010027.
组织蛋白酶 K 激活型骨吸收荧光探针对多发性骨髓瘤小鼠模型早期破骨细胞骨吸收的检测。
Bioconjug Chem. 2021 May 19;32(5):916-927. doi: 10.1021/acs.bioconjchem.1c00036. Epub 2021 May 6.
4
CY-09 attenuates the progression of osteoarthritis via inhibiting NLRP3 inflammasome-mediated pyroptosis.CY-09 通过抑制 NLRP3 炎性体介导的焦亡来减轻骨关节炎的进展。
Biochem Biophys Res Commun. 2021 May 14;553:119-125. doi: 10.1016/j.bbrc.2021.03.055. Epub 2021 Mar 22.
5
Increased Extracellular ATP in Plasma of Rheumatoid Arthritis Patients Activates CD8T Cells.类风湿关节炎患者血浆中细胞外 ATP 增加可激活 CD8T 细胞。
Arch Med Res. 2021 May;52(4):423-433. doi: 10.1016/j.arcmed.2020.12.010. Epub 2021 Feb 1.
6
BAFF, involved in B cell activation through the NF-κB pathway, is related to disease activity and bone destruction in rheumatoid arthritis.BAFF,通过 NF-κB 途径参与 B 细胞激活,与类风湿关节炎的疾病活动和骨破坏有关。
Acta Pharmacol Sin. 2021 Oct;42(10):1665-1675. doi: 10.1038/s41401-020-00582-4. Epub 2021 Jan 22.
7
Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial.达帕舒替瑞,一种口服选择性NLRP3炎性小体抑制剂,用于治疗痛风发作:一项开放标签、剂量适应性、概念验证的2a期试验。
Lancet Rheumatol. 2020 May;2(5):e270-e280. doi: 10.1016/s2665-9913(20)30065-5. Epub 2020 Apr 8.
8
Immunometabolism in the development of rheumatoid arthritis.免疫代谢在类风湿关节炎发病机制中的作用。
Immunol Rev. 2020 Mar;294(1):177-187. doi: 10.1111/imr.12838. Epub 2020 Jan 27.
9
TNF-α/calreticulin dual signaling induced NLRP3 inflammasome activation associated with HuR nucleocytoplasmic shuttling in rheumatoid arthritis.TNF-α/钙网织蛋白双重信号诱导 NLRP3 炎性体激活与类风湿关节炎中 HuR 的核质穿梭有关。
Inflamm Res. 2019 Jul;68(7):597-611. doi: 10.1007/s00011-019-01244-w. Epub 2019 May 22.
10
The NLRP3 inflammasome: molecular activation and regulation to therapeutics.NLRP3 炎性小体:分子激活与治疗调控。
Nat Rev Immunol. 2019 Aug;19(8):477-489. doi: 10.1038/s41577-019-0165-0.